The riboflavin biosynthetic pathway as a novel target for antifungal drugs against Candida species

ABSTRACT In recent decades, there has been an increase in the occurrence of fungal infections; yet, the arsenal of drugs available to fight invasive infections remains very limited. The development of new antifungal agents is hindered by the restricted number of molecular targets that can be exploit...

وصف كامل

التفاصيل البيبلوغرافية
الحاوية / القاعدة:mBio
المؤلفون الرئيسيون: Jana Nysten, Arne Peetermans, Dries Vaneynde, Stef Jacobs, Liesbeth Demuyser, Patrick Van Dijck
التنسيق: مقال
اللغة:الإنجليزية
منشور في: American Society for Microbiology 2024-11-01
الموضوعات:
الوصول للمادة أونلاين:https://journals.asm.org/doi/10.1128/mbio.02502-24

مواد مشابهة